ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 379,27
-0,80%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Taiwan Liposome Company Ltd (TLC)

  7. Taiwan Liposome Company Ltd (TLC) Actualités

TLC

Taiwan Liposome (TLC)

Taiwan Liposome Company Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TLC
DateHeureSourceTitreSymboleSociété
20/11/202309h54GlobeNewswire Inc.Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts SessionNASDAQ:TLCTaiwan Liposome Company Ltd
08/11/202310h54GlobeNewswire Inc.TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACRNASDAQ:TLCTaiwan Liposome Company Ltd
13/06/202212h30GlobeNewswire Inc.TLC Announces TLC599 Agreement with EndoNASDAQ:TLCTaiwan Liposome Company Ltd
07/03/202210h57GlobeNewswire Inc.TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & TherapyNASDAQ:TLCTaiwan Liposome Company Ltd
18/02/202222h04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TLCTaiwan Liposome Company Ltd
27/01/202212h13Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TLCTaiwan Liposome Company Ltd
15/10/202112h33Edgar (US Regulatory)Amended Tender Offer/rights Offering Notification (cb/a)NASDAQ:TLCTaiwan Liposome Company Ltd
15/09/202117h57Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:TLCTaiwan Liposome Company Ltd
08/09/202110h40GlobeNewswire Inc.TLC Announces Voluntary Delisting and Deregistration of American Depositary SharesNASDAQ:TLCTaiwan Liposome Company Ltd
26/08/202122h02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TLCTaiwan Liposome Company Ltd
12/08/202111h44GlobeNewswire Inc.TLC Reports Second Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
05/08/202120h38Edgar (US Regulatory)Tender Offer/rights Offering Notification (cb)NASDAQ:TLCTaiwan Liposome Company Ltd
05/07/202112h16GlobeNewswire Inc.TLC Announces Details of Stock Swap TransactionsNASDAQ:TLCTaiwan Liposome Company Ltd
26/05/202110h30GlobeNewswire Inc.TLC and Zydus Enter Agreement to Launch AmphoTLC™ in IndiaNASDAQ:TLCTaiwan Liposome Company Ltd
25/05/202111h05GlobeNewswire Inc.TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in IndiaNASDAQ:TLCTaiwan Liposome Company Ltd
23/05/202115h00GlobeNewswire Inc.InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...NASDAQ:TLCTaiwan Liposome Company Ltd
14/05/202113h32GlobeNewswire Inc.TLC Reports First Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
03/05/202111h15GlobeNewswire Inc.TLC Earns Highest Ranking in Corporate Governance Evaluation Seven Years RunningNASDAQ:TLCTaiwan Liposome Company Ltd
26/04/202111h30GlobeNewswire Inc.InspirMed to Present at the 23rd International Society for Aerosols in Medicine (ISAM) CongressNASDAQ:TLCTaiwan Liposome Company Ltd
02/03/202110h00GlobeNewswire Inc.TLC to Present at Upcoming Virtual Investor ConferencesNASDAQ:TLCTaiwan Liposome Company Ltd
16/02/202118h06Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TLCTaiwan Liposome Company Ltd
12/02/202122h28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TLCTaiwan Liposome Company Ltd
05/02/202110h15GlobeNewswire Inc.TLC Reports Fiscal Year End 2020 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
04/01/202111h00GlobeNewswire Inc.TLC Announces Completion of US$15 Million Financing for Subsidiary InspirMed Inc.NASDAQ:TLCTaiwan Liposome Company Ltd
28/12/202010h00GlobeNewswire Inc.TLC Announces Full Patient Enrollment in EXCELLENCE Trial of TLC599 for Osteoarthritis PainNASDAQ:TLCTaiwan Liposome Company Ltd
18/12/202010h00GlobeNewswire Inc.TLC Provides Corporate Update at Investor ConferenceNASDAQ:TLCTaiwan Liposome Company Ltd
03/11/202013h37GlobeNewswire Inc.TLC Announces Acceptance of Manuscript on Anti-COVID-19 Program by Clinical and Translational Science JournalNASDAQ:TLCTaiwan Liposome Company Ltd
28/10/202009h50GlobeNewswire Inc.TLC Reports Third Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:TLCTaiwan Liposome Company Ltd
21/10/202010h45GlobeNewswire Inc.TLC Announces the Appointment of Thomas H. Bliss, Jr., MBA, as Chief Business OfficerNASDAQ:TLCTaiwan Liposome Company Ltd
14/10/202010h40GlobeNewswire Inc.TLC Enrolls First Subject in Phase I Clinical Trial of Inhalable Anti-COVID-19 Program (TLC19)NASDAQ:TLCTaiwan Liposome Company Ltd
 Showing the most relevant articles for your search:NASDAQ:TLC

Dernières Valeurs Consultées

EU
CS
Axa
EU
CAP
Capgemini
EU
BN
Danone
NASDAQ
NVDA
NVIDIA
EU
LR
Legrand
NASDAQ
AMZN
Amazon.com
EU
MC
Lvmh Moet Hennessy Louis...
USI
USTECH100
US Tech 100
FTSE
UKX
FTSE 100
NASDAQ
AAPL
Apple
EU
VK
Vallourec
EU
BNP
BNP Paribas
COIN
ETHUSD
Ethereum
EU
RNO
Renault
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés